Warrants (Details) |
9 Months Ended |
|---|---|
|
Oct. 31, 2020
$ / shares
shares
| |
| Warrants | |
| Warrants outstanding shares, Beginning | shares | 2,675,000 |
| Exercised, shares | shares | (190,000) |
| Granted, shares | shares | 2,731,000 |
| Warrants outstanding shares, Ending | shares | 5,216,000 |
| Warrants outstanding weighted average conversion price, Beginning | $ / shares | $ 1.00 |
| weighted average conversion price, Exercised | $ / shares | 1.32 |
| Weighted average conversion price, Granted | $ / shares | 4.41 |
| Warrants outstanding weighted average conversion price, Ending | $ / shares | $ 2.77 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Change in the weighted average exercise price of options outstanding. No definition available.
|